Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 3
1(50.0%)
Phase 4
1(50.0%)
2Total
Phase 3(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06760078Phase 4Not Yet Recruiting

Tranexamic Acid with Intensive Blood Pressure Management in Ultra-Early Intracerebral Hemorrhage

Role: collaborator

NCT05028855Recruiting

Cerebral Autoregulation in Patients With Symptomatic Cerebral Atherosclerotic Stenosis

Role: collaborator

NCT05159947Phase 3Unknown

SPT-07A Injection in Patients With Acute Ischemic Stroke (AIS): A Phase III Clinical Trial

Role: collaborator

NCT04958447Unknown

Nutritional Management in Respiratory Critically Ill Patients -an Observational Study in Mainland China

Role: collaborator

NCT03417063Unknown

Intracranial Artery Stenosis Magnetic Resonance Imaging: Aetiology and Progression

Role: collaborator

All 5 trials loaded